Myocardial cathepsin D is downregulated in sudden cardiac death

Yu Kakimoto1, Ayumi Sasaki2, Maki Niioka2

  • 1Department of Forensic Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.

Plos One
|March 17, 2020
PubMed

Insights

Cardiac cathepsins (CTSB, CTSD, CTSL) are key lysosomal proteases. Aging increases CTSB and CTSD, while downregulation of CTSD may link to sudden cardiac death with hypertrophy.

Area of Science:

  • Biochemistry
  • Cardiovascular Biology
  • Molecular Medicine

Background:

  • Cathepsins are essential lysosomal proteases regulating cellular functions.
  • Understanding cathepsin roles in cardiac pathology is crucial for disease management.

Purpose of the Study:

  • To investigate myocardial cathepsin expression changes in aging, cardiac hypertrophy, and sudden cardiac death (SCD).
  • To explore the potential link between cathepsin alterations and pathological cardiac conditions.

Main Methods:

  • Autopsy-derived cardiac tissue and serum samples from control, compensated cardiac hypertrophy (CCH), and SCD with cardiac hypertrophy (SCH) groups.
  • Immunoblotting for cathepsin B, D, L (CTSB/D/L) and targets.
  • Immunohistochemistry and ELISA for CTSD.

Main Results:

  • Cardiac CTSB and CTSD increased with age.
  • CTSD was significantly downregulated in SCH, and CTSL in CCH.
  • Myocardial and serum CTSD levels were lower in SCH cases.
  • No significant changes in p62, ATPSC, or ASNC were observed in hypertrophy.

Conclusions:

  • Upregulation of cardiac CTSB and CTSD with age may serve a compensatory proteolytic function.
  • Downregulation of CTSD is potentially associated with sudden cardiac death in the context of cardiac hypertrophy.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
361
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
297
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
704
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
604
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
284
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
418